Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.
Muri J, Cecchinato V, Cavalli A, Shanbhag AA, Matkovic M, Biggiogero M, Maida PA, Moritz J, Toscano C, Ghovehoud E, Furlan R, Barbic F, Voza A, De Nadai G, Cervia C, Zurbuchen Y, Taeschler P, Murray LA, Danelon-Sargenti G, Moro S, Gong T, Piffaretti P, Bianchini F, Crivelli V, Podešvová L, Pedotti M, Jarrossay D, Sgrignani J, Thelen S, Uhr M, Bernasconi E, Rauch A, Manzo A, Ciurea A, Rocchi MBL, Varani L, Moser B, Bottazzi B, Thelen M, Fallon BA, Boyman O, Mantovani A, Garzoni C, Franzetti-Pellanda A, Uguccioni M, Robbiani DF. Muri J, et al. Among authors: zurbuchen y. Nat Immunol. 2023 Apr;24(4):604-611. doi: 10.1038/s41590-023-01445-w. Epub 2023 Mar 6. Nat Immunol. 2023. PMID: 36879067 Free PMC article.
The role of cytokines in T-cell memory in health and disease.
Raeber ME, Zurbuchen Y, Impellizzieri D, Boyman O. Raeber ME, et al. Among authors: zurbuchen y. Immunol Rev. 2018 May;283(1):176-193. doi: 10.1111/imr.12644. Immunol Rev. 2018. PMID: 29664568 Free article. Review.
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, Hasler S, Bosshard PP, De Cecco E, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Zinkernagel AS, Schaer DJ, Aguzzi A, Kochs G, Held U, Probst-Müller E, Rampini SK, Boyman O. Cervia C, et al. Among authors: zurbuchen y. J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9. doi: 10.1016/j.jaci.2020.10.040. Epub 2020 Nov 20. J Allergy Clin Immunol. 2021. PMID: 33221383 Free PMC article.
A distinct innate immune signature marks progression from mild to severe COVID-19.
Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, Sivapatham S, Jacobs A, Bachli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Nilsson J, Boyman O, Bodenmiller B. Chevrier S, et al. Among authors: zurbuchen y. Cell Rep Med. 2020 Dec 26;2(1):100166. doi: 10.1016/j.xcrm.2020.100166. eCollection 2021 Jan 19. Cell Rep Med. 2020. PMID: 33521697 Free PMC article.
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.
Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, Sivapatham S, Jacobs A, Baechli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Bodenmiller B, Boyman O, Nilsson J. Adamo S, et al. Among authors: zurbuchen y. Allergy. 2021 Sep;76(9):2866-2881. doi: 10.1111/all.14866. Epub 2021 Jun 30. Allergy. 2021. PMID: 33884644 Free PMC article.
Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection.
Adamo S, Michler J, Zurbuchen Y, Cervia C, Taeschler P, Raeber ME, Baghai Sain S, Nilsson J, Moor AE, Boyman O. Adamo S, et al. Among authors: zurbuchen y. Nature. 2022 Feb;602(7895):148-155. doi: 10.1038/s41586-021-04280-x. Epub 2021 Dec 7. Nature. 2022. PMID: 34875673 Free PMC article.
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.
Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Nilsson J, Held U, Puhan MA, Boyman O. Cervia C, et al. Among authors: zurbuchen y. Nat Commun. 2022 Jan 25;13(1):446. doi: 10.1038/s41467-021-27797-1. Nat Commun. 2022. PMID: 35078982 Free PMC article.
T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
Taeschler P, Adamo S, Deng Y, Cervia C, Zurbuchen Y, Chevrier S, Raeber ME, Hasler S, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Bodenmiller B, Boyman O, Nilsson J. Taeschler P, et al. Among authors: zurbuchen y. Allergy. 2022 Aug;77(8):2468-2481. doi: 10.1111/all.15372. Epub 2022 Jun 2. Allergy. 2022. PMID: 35567391 Free PMC article.
13 results